ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prognostic value of Holliday junction-recognizing protein and its correlation with immune infiltrates in lung adenocarcinoma

Chen, Long; Zeng, Chong; Yan, Limei; Liao, Wanyu; Zhen, Chen; Yao, Jie*南方医科大学; 1
Oncology Letters2022-7DOI: 10.3892/ol.2022.13353
3被引16阅读
引用收藏
分享

摘要

Lung adenocarcinoma (LUAD) is a disease with high morbidity and mortality rates globally. Holliday junction-recognizing protein (HJURP) has recently been shown to be a potentially useful biomarker for diagnosing and determining the progression and prognosis of different cancer types. The present study assessed the prognostic value of HJURP expression in LUAD and investigated the biological pathways related to HJURP that are involved in LUAD pathogenesis. It was found that high HJURP expression was significantly associated with stage (P=0.001), T grade (P=0.012) and N grade (P=0.012). Overall survival analysis demonstrated that patients with LUAD and high HJURP expression had a worse prognosis compared with those patients with low HJURP expression (P<0.001). Multivariate analysis using the Cox proportional hazards model indicated that the expression of HJURP [hazard ratio (HR), 1.32; 95% confidence interval (CI), 1.09-1.60; P=0.004] and stage (HR, 1.90; 95% CI, 1.19-3.03; P=0.007) were independent prognostic factors for patients with LUAD. Gene set enrichment analysis results showed that genes involved with 'basal transcription factors', the 'cell cycle', 'homologous recombination', 'non-small cell lung cancer' (NSCLC), 'oocyte meiosis', 'p53 signaling pathway', 'pathways in cancer', 'RNA degradation' and 'spliceosome' were differentially enriched in the high HJURP expression phenotype. Significant correlations were also found between HJURP and several tumor-infiltrating immune cells, immunomodulators and immune subtypes. Furthermore, western blotting and qPCR analyses confirmed that HJURP was significantly increased in cell lines of NSCLC. In summary, HJURP may be a potentially useful prognostic molecular biomarker of a poor prognosis in LUAD cases. Further experiments are needed to demonstrate the biological effects of HJURP.

学科与关键词

关键词
lung adenocarcinomaHJURPimmune infiltrationprognosis
相关
加载中…
  • TTYH3 is a Prognostic Biomarker and Associates with Immune Cell Infiltrations of Lung Adenocarcinoma
    Xu, Jian; Chen, Jiming; Duan, Honglu; Zhang, Dandan; Li, Yilu; Xu, Xiaoni; Li, Xiaoli*INTERNATIONAL JOURNAL OF MORPHOLOGY, 2023, 41(1): 118-133.
  • CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
    Tan, Jianlong; Chen, Fengyu; Ouyang, Bin; Li, Xiuying; Zhang, Weidong; Gao, Xinglin*Frontiers in Oncology, 2022, 12: 865756.被引 3
  • Expression and Gene Regulation Network of Adenosine Receptor A2B in Lung Adenocarcinoma: A Potential Diagnostic and Prognostic Biomarker
    Sui, Yutong; Liu, Jiayin; Zhang, Jing; Zheng, Zena; Wang, Ziwei; Jia, Zhenghu*; Meng, Ziyu*Frontiers in Molecular Biosciences, 2021, 8: 663011.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Oncology Letters
发表日期
2022-07
卷期
第 24 卷, 第 1 期
页码
232
DOI
10.3892/ol.2022.13353
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • C

    Chen, Long (第一作者)

    1 · southern med univ

  • Z

    Zeng, Chong

    1 · southern med univ

查看全部 6 位作者收起作者
  • Y

    Yan, Limei

    1 · southern med univ

  • L

    Liao, Wanyu

    1 · southern med univ

  • Z

    Zhen, Chen

    1 · southern med univ

  • Y

    Yao, Jie (通讯)

    1 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417